Giuseppe Lapadula

6.8k total citations
91 papers, 1.8k citations indexed

About

Giuseppe Lapadula is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Giuseppe Lapadula has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 35 papers in Virology and 29 papers in Epidemiology. Recurrent topics in Giuseppe Lapadula's work include HIV/AIDS drug development and treatment (42 papers), HIV Research and Treatment (33 papers) and HIV/AIDS Research and Interventions (30 papers). Giuseppe Lapadula is often cited by papers focused on HIV/AIDS drug development and treatment (42 papers), HIV Research and Treatment (33 papers) and HIV/AIDS Research and Interventions (30 papers). Giuseppe Lapadula collaborates with scholars based in Italy, United Kingdom and United States. Giuseppe Lapadula's co-authors include Andrea Gori, Christophe Copéret, Matthew P. Conley, Andrea Antinori, Antonella d’Arminio Monforte, Alessandro Cozzi‐Lepri, Carlo Torti, Giulia Marchetti, Eugenia Quirós-Roldán and Emanuele Nicastri and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Giuseppe Lapadula

85 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Lapadula Italy	25	700	481	437	426	333	91	1.8k
D. B. Hall United States	23	578 0.8×	257 0.5×	955 2.2×	312 0.7×	50 0.2×	34	3.5k
Lionel Perrin France	37	1.5k 2.1×	1.1k 2.4×	1.1k 2.6×	561 1.3×	267 0.8×	154	5.7k
Antonella Cingolani Italy	37	1.9k 2.7×	1.4k 2.8×	1.1k 2.5×	124 0.3×	464 1.4×	159	4.4k
Milan Kožíšek Czechia	22	326 0.5×	255 0.5×	167 0.4×	208 0.5×	18 0.1×	51	1.4k
Shuguang Chen China	18	798 1.1×	548 1.1×	248 0.6×	36 0.1×	121 0.4×	57	1.8k
Subhra Mandal United States	26	327 0.5×	249 0.5×	99 0.2×	624 1.5×	52 0.2×	57	1.9k
Anik Peeters Belgium	17	294 0.4×	249 0.5×	73 0.2×	292 0.7×	25 0.1×	39	1.3k
Denise Evans South Africa	22	967 1.4×	212 0.4×	556 1.3×	454 1.1×	197 0.6×	119	2.5k
Wolfgang Schramm Germany	25	173 0.2×	160 0.3×	149 0.3×	104 0.2×	54 0.2×	78	1.4k
Norbert Wagner Germany	36	281 0.4×	74 0.2×	316 0.7×	356 0.8×	16 0.0×	138	4.8k

Countries citing papers authored by Giuseppe Lapadula

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Lapadula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Lapadula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Lapadula more than expected).

Fields of papers citing papers by Giuseppe Lapadula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Lapadula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Lapadula. The network helps show where Giuseppe Lapadula may publish in the future.

Co-authorship network of co-authors of Giuseppe Lapadula

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Lapadula. A scholar is included among the top collaborators of Giuseppe Lapadula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Lapadula. Giuseppe Lapadula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lanini, Simone, Andrea De Vito, Maria Mazzitelli, et al.. (2025). All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort. Open Forum Infectious Diseases. 12(8). ofaf455–ofaf455.

Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2024). Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition. AIDS and Behavior. 28(7). 2258–2263. 2 indexed citations

Gagliardini, Roberta, Alessandro Tavelli, Giuseppe Lapadula, et al.. (2024). OC-10 Effectiveness of long-acting art with cabotegravir/rilpivirine in the icona cohort. A8–A9.

Allouche, Florian, Md. Ashraful Islam, Kevin J. Sanders, et al.. (2024). Geometry and electronic structure of Yb( iii )[CH(SiMe ₃ ) ₂ ] ₃ from EPR and solid-state NMR augmented by computations. Physical Chemistry Chemical Physics. 26(11). 8734–8747. 3 indexed citations

Vergori, Alessandra, Nicola Gianotti, Alessandro Tavelli, et al.. (2024). Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic. Viruses. 16(12). 1822–1822.

Caputo, Sergio Lo, Alessandro Tavelli, Roberta Gagliardini, et al.. (2024). Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study. International Journal of Infectious Diseases. 143. 106956–106956. 2 indexed citations

Castelli, Francesco, Antonio Di Biagio, Antonella d’Arminio Monforte, et al.. (2023). Influence of efavirenz and 8‐hydroxy‐efavirenz plasma levels on cognition and central nervous system side effects. HIV Medicine. 25(4). 491–497. 2 indexed citations

Benedetto, Ilaria De, Marianna Rossi, Giuseppe Lapadula, et al.. (2022). BCGitis after Bacille CalmetteGuerin intravesical administration from two referral centers: clinical characteristics and risk factors. Infezioni in Medicina. 30(2). 242–246. 3 indexed citations

Bresciani, Elena, Nicola Squillace, Valentina Orsini, et al.. (2022). miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis. International Journal of Molecular Sciences. 23(7). 3486–3486. 4 indexed citations

10.

Lapadula, Giuseppe, Davide Paolo Bernasconi, Francesca Bai, et al.. (2019). Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances. AIDS. 34(1). 53–61. 12 indexed citations

11.

Delley, Murielle F., Giuseppe Lapadula, Francisco Núñez‐Zarur, et al.. (2017). Local Structures and Heterogeneity of Silica-Supported M(III) Sites Evidenced by EPR, IR, NMR, and Luminescence Spectroscopies. Journal of the American Chemical Society. 139(26). 8855–8867. 59 indexed citations

12.

Biagio, Antonio Di, P Lorenzini, Giulia Gustinetti, et al.. (2017). Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation. AIDS Patient Care and STDs. 31(12). 487–494. 4 indexed citations

13.

Quirós-Roldán, Eugenia, Simona Di Giambenedetto, Nicoletta Ladisa, et al.. (2016). Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine ATV/r in Patients with Preserved Renal Function. The Open AIDS Journal. 10(1). 136–143. 5 indexed citations

14.

Costarelli, Silvia, Alessandro Cozzi‐Lepri, Giuseppe Lapadula, et al.. (2016). Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice. PLoS ONE. 11(10). e0160761–e0160761. 7 indexed citations

15.

Mussini, Cristina, P Lorenzini, Massimo Puoti, et al.. (2015). Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus. PLoS ONE. 10(12). e0140877–e0140877. 10 indexed citations

16.

Lapadula, Giuseppe, Fabio Zanini, & Luigi Ruffo Codecasa. (2013). INFLUENCE OF HOSPITALIZATION UPON DIAGNOSIS ON THE RISK OF TUBERCULOSIS CLUSTERING. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013071–e2013071. 1 indexed citations

17.

Albini, Laura, Bruno Mario Cesana, Davide Motta, et al.. (2011). A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 18–24. 34 indexed citations

18.

Costarelli, Silvia, Carlo Torti, Anna Rodella, et al.. (2008). Screening and Management of HIV-2-Infected Individuals in Northern Italy. AIDS Patient Care and STDs. 22(6). 489–494. 12 indexed citations

19.

Quirós-Roldán, Eugenia, Carlo Torti, Giuseppe Lapadula, et al.. (2007). Adherence And Plasma Drug Concentrations Are Predictors of Confirmed Virologic Response after 24-Week Salvage Highly Active Antiretroviral Therapy. AIDS Patient Care and STDs. 21(2). 92–99. 4 indexed citations

20.

Uccelli, Maria Cristina, Carlo Torti, Giuseppe Lapadula, et al.. (2006). Influence of Folate Serum Concentration on Plasma Homocysteine Levels in HIV-Positive Patients Exposed to Protease Inhibitors Undergoing HAART. Annals of Nutrition and Metabolism. 50(3). 247–252. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact